Kromann Sofie, Olsen Rikke Heidemann, Bojesen Anders Miki, Jensen Henrik Elvang, Thøfner Ida
Department of Veterinary and Animal Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, 1870 Frederiksberg, Denmark.
DanHatch Denmark A/S, Rugerivej 26, 9760 Vrå, Denmark.
Vaccines (Basel). 2021 Oct 22;9(11):1233. doi: 10.3390/vaccines9111233.
In poultry, is a common cause of high-cost infections. Consequently, autogenous vaccines are often used despite limited and conflicting evidence on their effectiveness have been presented. The present study aimed to investigate the efficacy of a commonly used autogenous vaccine, previously deemed ineffective, in an aerosol model of colibacillosis.
Broiler breeders ( = 47) were randomly allocated to one of four groups (vaccinated and unvaccinated birds receiving an autogenous vaccine or sterile saline intramuscularly) and challenged with either aerosolised or vehicle at 29 weeks of age. Two days following inoculation, the birds were euthanised, thoroughly necropsied, and samples for bacteriology and histopathology were collected.
Vaccinated birds had a significantly lower bacteriology score compared to the unvaccinated group challenged with ( < 0.01) and a lower overall air sac lesion score ( < 0.05). Overall lung and spleen lesion scores only differed significantly between the unvaccinated challenged group compared to the vehicle inoculated groups. The overall gross pathology score was 2.8 and 1.95 in the unvaccinated and vaccinated challenge groups, respectively, whereas the vaccinated vehicle group had a score of 0.9 and the unvaccinated vehicle group a score of 1.
A protective effect of an autogenous vaccine was found utilising an aerogenous model of colibacillosis through multiple methods of evaluation. The findings encourage the continued use of autogenous vaccines and underlines the necessity of discriminative experimental models with high predictive validity when evaluating vaccine interventions.
在家禽中,[病原体名称未给出]是高成本感染的常见原因。因此,尽管关于其有效性的证据有限且相互矛盾,但自体疫苗仍经常被使用。本研究旨在调查一种常用的自体疫苗(此前被认为无效)在大肠杆菌病气溶胶模型中的疗效。
将47只肉种鸡随机分为四组(接种疫苗和未接种疫苗的鸡分别肌肉注射自体疫苗或无菌生理盐水),并在29周龄时用雾化的[病原体名称未给出]或载体进行攻毒。接种后两天,对鸡实施安乐死,进行全面尸检,并采集细菌学和组织病理学样本。
与用[病原体名称未给出]攻毒的未接种疫苗组相比,接种疫苗的鸡的细菌学评分显著更低(P<0.01),总体气囊病变评分也更低(P<0.05)。仅在未接种疫苗的[病原体名称未给出]攻毒组与接种载体组之间,总体肺和脾病变评分存在显著差异。未接种疫苗的[病原体名称未给出]攻毒组和接种疫苗的[病原体名称未给出]攻毒组的总体大体病理学评分分别为2.8和1.95,而接种疫苗的载体组评分为0.9,未接种疫苗的载体组评分为1。
通过多种评估方法,在大肠杆菌病气溶胶模型中发现了自体疫苗的保护作用。这些发现鼓励继续使用自体疫苗,并强调在评估疫苗干预措施时,具有高预测效度的判别性实验模型的必要性。